KRAS and pancreatic adenocarcinoma: For this purpose, we used The Cancer Genome Atlas (TCGA) database of pancreatic adenocarcinoma patients with low and high expression of polymerase theta carrying KRAS wild-type or oncogenic KRASG12D to generate a survival curve.